New research: Slowing the spread of brain cancer
By Alicia Bienkowski | Brain, Brain Cancer, Cancer, Cancer, Cancer 200 Ride, Disease Area, Lab, News & Events, Research Area, Systems Biology and GenomicsA new study involving researchers from the Harry Perkins Institute of Medical Research has uncovered a potential way to slow the growth and spread of one of the deadliest forms…
Stem cell grant to accelerate research into rare childhood brain disorders
By Richard Schoonraad | Brain, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases Program, Neurological Disorders, News & Events, ResearchResearchers from Western Australia and South Australia have been awarded $960,000 through the Medical Research Future Fund’s 2024 Stem Cell Therapies Mission to develop advanced stem cell-based models that could…
New technology revealing genetics of recurrent pregnancy loss
By Richard Schoonraad | Community, Disease Area, Genes, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Rare Disease Genetics and Functional Genomics, Research AreaEvery day in Australia, 282 women experience a miscarriage, according to the The Pink Elephants Support Network. Chromosomal abnormalities are one of the more commonly recognised causes of recurrent miscarriage.…
Perth gains NATA-accreditation for rare disease diagnostic tool
By Richard Schoonraad | Disease Area, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Media Releases, Muscles, Muscular Dystrophy, News & Events, Research, Research AreaResearchers at Perth’s Harry Perkins Institute of Medical Research and PathWest Laboratory Medicine WA are celebrating the long-awaited nationally recognised accreditation of a world-leading diagnostic technology that will provide faster,…
Lowering cancer drug dose could open tumours to immunotherapy
By Alicia Bienkowski | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and GenomicsGroundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…
Genetic Variants Linked to Severe Form of Muscular Dystrophy
By Alicia Bienkowski | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Lab, Muscular Dystrophy, News & Events, Rare Disease Genetics and Functional Genomics, ResearchResearchers from Perth’s Harry Perkins Institute of Medical Research have led a study that uncovered changes in a gene associated with a rare and severe form of muscular dystrophy. The…
Gene Mutation Discovery Sheds Light on Rare Muscle Disorder
By Alicia Bienkowski | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Lab, Muscular Dystrophy, News & Events, Rare Disease Genetics and Functional Genomics, ResearchA groundbreaking study led by Dr Mridul Johari and Associate Professor Gina Ravenscroft, has identified that a genetic mutation is responsible for a rare and debilitating form of congenital myopathy.…
Perkins Represented in Premiers Science Awards
By Richard Schoonraad | Antibiotic diagnostics, awards, BioDiscovery, Community, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Disease, Lungs, Media Releases, News & Events, ResearchThree celebrated scientists from WA’s Harry Perkins Institute of Medical Research, have been named as finalists in the 2024 Premier’s Science Awards. Associate Professor Gina Ravenscroft, Dr Kieran Mulroney and…